scholarly journals Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis

Critical Care ◽  
2010 ◽  
Vol 14 (1) ◽  
pp. R20 ◽  
Author(s):  
Pascal Augustin ◽  
Nathalie Kermarrec ◽  
Claudette Muller-Serieys ◽  
Sigismond Lasocki ◽  
Denis Chosidow ◽  
...  
Keyword(s):  
Risk Factors ◽  
Antibiotic Therapy ◽  
Multidrug Resistant ◽  
Postoperative Peritonitis ◽  
Resistant Bacteria ◽  
Empirical Antibiotic Therapy ◽  
Multidrug Resistant Bacteria

SAT-045-Prevalence, type and risk factors of colonization by multidrug-resistant bacteria in a large series of patients with decompensated cirrhosis

2019 ◽  
Vol 70 (1) ◽  
pp. e646-e647
Author(s):  
Maria Hernandez-Tejero ◽  
Fatima Aziz ◽  
Cristina Pitart ◽  
Francesc Marco Reverte ◽  
Irene Campo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Multidrug Resistant ◽  
Large Series ◽  
Decompensated Cirrhosis ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria

scholarly journals Multidrug resistant bacteria in critically ill patients: a step further antibiotic therapy

2018 ◽  
Vol 2 ◽  
pp. 103-103 ◽  
Author(s):  
Martina Tosi ◽  
Erika Roat ◽  
Sara De Biasi ◽  
Elena Munari ◽  
Sophie Venturelli ◽  
...  
Keyword(s):  
Antibiotic Therapy ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria

Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care – Prevalence and risk factors

2013 ◽  
Vol 303 (8) ◽  
pp. 405-409 ◽  
Author(s):  
Isabella Gruber ◽  
Ursel Heudorf ◽  
Guido Werner ◽  
Yvonne Pfeifer ◽  
Can Imirzalioglu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Nursing Homes ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria

Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation

2016 ◽  
Vol 18 (1) ◽  
pp. 22-30 ◽  
Author(s):  
G. Tebano ◽  
C. Geneve ◽  
S. Tanaka ◽  
N. Grall ◽  
E. Atchade ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Transplantation ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria

scholarly journals Nosocomial Infections Due to Multidrug-Resistant Bacteria in Cancer Patients: A Seven-Year Experience of an Oncology Center in Western China

2020 ◽  
Author(s):  
Ai-Min Jiang ◽  
Xin Shi ◽  
Na Liu ◽  
Huan Gao ◽  
Meng-Di Ren ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Disease ◽  
Cancer Patients ◽  
Nosocomial Infections ◽  
Multidrug Resistant ◽  
Western China ◽  
Resistant Bacteria ◽  
Klebsiella Pneumonia ◽  
Multidrug Resistant Bacteria ◽  
Antibiotic Resistant

Abstract Background: Bacterial infections are the most frequent complications in patients with malignancy, and the epidemiology of nosocomial infections among cancer patients has changed over time. This study aimed to evaluate characteristics, antibiotic-resistant patterns, and prognosis of nosocomial infections caused by multidrug-resistant bacteria (MDR) in cancer patients. Methods: This retrospectively analyzed cancer patients with MDR bacteria caused nosocomial infections from August 2013 to May 2019 and was conducted to explore the risk factors, clinical features, outcomes, and antibiotic-resistant patterns of these infections. Results: Overall, 257 cancer patients developed nosocomial infections caused by MDR bacteria. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae was the most frequently isolated multidrug-resistant Gram-negative bacteria (MDRGNB), followed by ESBL-producing Klebsiella pneumonia, and Acinetobacter baumannii. Cancer patients with liver disease, received intrapleural/abdominal infusion within 30 days, length of hospitalization, hemoglobin, and albumin were independent factors for 30-day mortality in the study population. The isolated MDR bacteria were highly sensitive to amikacin, meropenem, imipenem, tigecycline, and piperacillin/tazobactam. Conclusions: Cancer patients with prolonged hospitalization was an independent predictor of a favorable outcome. However, cancer patients with liver disease, received intrapleural/abdominal infusion within 30 days, anemia, and hypoproteinemia were independent risk factors of 30-day mortality.

Sign in / Sign up

Export Citation Format

Share Document